The best indicator for Accenture (ACN)
We backtested 366 indicators across daily, weekly and hourly charts on real Accenture (ACN) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Negative Volume Index
On the daily chart, this is the strongest risk-adjusted edge we found for Accenture (ACN) over ~24.8 years — beating buy-and-hold by 0.1% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Accenture (ACN) — trailing buy-and-hold by 9.8% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Negative Volume Index ✓ | Daily | 12.2% | 0.61 | -34.8% | 56.9% | 58 | 0.1% |
| 2 | WMA 200 Trend ✓ | Weekly | 9.4% | 0.55 | -53.9% | 46.7% | 15 | -2.6% |
| 3 | Vortex ✓ | Weekly | 8.7% | 0.54 | -43.8% | 66.7% | 60 | -3.3% |
| 4 | WMA 100 Trend ✓ | Weekly | 8.5% | 0.52 | -42.4% | 52.0% | 25 | -3.6% |
| 5 | ALMA 200 Trend ✓ | Weekly | 8.0% | 0.52 | -42.4% | 50.0% | 16 | -4.1% |
| 6 | CCI (100) ✓ | Weekly | 8.8% | 0.52 | -52.3% | 62.5% | 16 | -3.2% |
| 7 | Random Walk Index ✓ | Weekly | 8.1% | 0.51 | -48.5% | 64.4% | 59 | -4.0% |
| 8 | EMA 100 Trend ✓ | Weekly | 8.6% | 0.51 | -56.6% | 52.0% | 25 | -3.5% |
| 9 | Disparity (100) ✓ | Weekly | 8.6% | 0.51 | -56.6% | 52.0% | 25 | -3.5% |
| 10 | Random Walk Index ✓ | Weekly | 8.1% | 0.51 | -48.5% | 64.4% | 59 | -4.0% |
| 11 | Guppy Multiple MA ✓ | Weekly | 9.9% | 0.58 | -27.5% | 69.2% | 13 | -2.2% |
| 12 | DeMarker ✓ | Daily | 8.6% | 0.5 | -51.1% | 80.7% | 83 | -3.5% |
| 13 | VIDYA 10/30 Cross ✓ | Daily | 8.7% | 0.5 | -49.7% | 62.5% | 24 | -3.4% |
| 14 | Projection Bands ✓ | Daily | 8.1% | 0.5 | -29.8% | 68.8% | 218 | -4.0% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Accenture (ACN), Negative Volume Index on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.